Verastem (VSTM) Tops Q2 EPS by 3c
Tweet
Share
E-mailVerastem (NASDAQ: VSTM) reported Q2 EPS of ($0.42), $0.03 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Verastem (VSTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Isabella Bank added to Russell 2000 index after Nasdaq listing
- Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
